Summary
Transforming growth factor-β (TGF-β) is a multifunctional polypeptide that inhibits cellular proliferation in most epithelial cells. cdk4 and several cyclin-dependent kinase (cdk) inhibitors (p15INK4B, p21WAF1/Cip1 and p27Kip1) have been implicated in the TGF-β-induced cell cycle arrest. More recently, down-regulation of Cdc25A, a cdk activator, was additionally suggested as a mechanism underlying growth inhibition by TGF-β. The existence of diverse cellular mediators of TGF-β, however, raises the question of whether their involvement might occur in a redundant manner or coordinately in a certain cell type. Using two TGF-β-sensitive gastric carcinoma cell lines (SNU-16 and -620), we addressed the contributory roles of several cdk inhibitors, and of cdk4 and Cdc25A, in TGF-β-induced cell cycle arrest by comparing their temporal expression pattern in response to TGF-β. Among the cdk inhibitors examined, p21 mRNA was most rapidly (in less than 1 h) and prominently induced by TGF-β. In contrast, p15 mRNA was more slowly induced than p21 in SNU-620 cells, and not expressed in SNU-16 cells harbouring homozygous deletion of p15. Western blotting results confirmed the rapid increase of p21, while opposite patterns of p27 expression were observed in the two cell lines. The down-regulation of Cdc25A mRNA occurred, but was more delayed than that of p15 or p21. Until G1 arrest was established, changes in the protein levels of both Cdc25A and cdk4 were marginal. Co-immunoprecipitation with anti-cdk4 antibody showed that induced p21 associates with cdk4 and that its kinase activity is reduced by TGF-β, which kinetically correlates closely with G1 arrest following TGF-β treatment of both cell lines. These results suggest that in certain human epithelial cells, p21 may play an early role in TGF-β-induced cell cycle arrest, and its cooperation with other cdk inhibitors is different depending on cell type. Delayed down-regulation of Cdc25A and cdk4 may contribute to cell adaptation to the quiescent state in the two gastric carcinoma cell lines studied.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Alexandorw, M. G. & Moses, H. L. (1995). Transforming growth factor β and cell cycle regulation. Cancer Res 55: 1452–1457.
Carmichael, J., Degraff, W. G., Gazdar, A. F., Minna, J. D. & Mitchell, J. B. (1987). Evaluation of tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936–942.
Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159.
Datto, M. B., Li, Y., Panus, J. F., Howe, D. J., Xiong, Y. & Wang, X. (1995). Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 92: 5545–5549.
Ewen, M. E., Sluss, H. K., Whitehouse, L. L. & Livingston, D. M. (1993). TGF-β inhibition of CDK4 synthesis is linked to cell cycle arrest. Cell 74: 1009–1020.
Filmus, J. & Kerbel, R. (1993). Development of resistant mechanisms to the growth inhibitory effects of transforming growth factor-β during tumor progression. Curr Opin Oncol 5: 123–129.
Geng, Y. & Weinberg, R. A. (1993). Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci USA 90: 10315–10319.
Hannon, G. J. & Beach, D. (1994). p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257–261.
Iavarone, A. & Massague, J. (1997). Repression of the CDK activator Cdc25A and cell cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature 387: 417–422.
Kaelin, W. G., Pallas, D. C., Decaprio, J. A., Kaye, F. J. & Livingston, D. M. (1991). Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell 64: 521–532.
Kim, J. H., Takahashi, T., Chiba, I., Park, J. G., Birrer, M. J., Roh, J. K., Lee, H. D., Kim, J. P., Minna, J. D. & Gazdar, A. F. (1991). Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines. J Natl Cancer Inst 83: 938–943.
Lee, Y. Y., Kang, S. H., Seo, J. Y., Jung, C. W., Lee, K. U., Choe, K. J., Kim, B. K., Kim, N. K., Koeffler, H. P. & Bang, Y-J (1997). Alteration of p16INK4A and p15INK4B genes in gastric carcinomas. Cancer 80: 1889–1896.
Li, C., Suardet, L. & Little, J. B. (1995). Potential role of WAF1/Cip1/p21 as a mediator of TGF-β cytoinhibitory effect. J Biol Chem 270: 4971–4974.
Markowitz, S. D. & Roberts, A. B. (1996). Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev 7: 93–102.
Massague, J. (1990). The transforming growth factor-β family. Annu Rev Cell Biol 6: 597–641.
Nasmyth, K. & Hunt, T. (1993). Cell cycle. Dams and sluices. Nature 366: 634–635.
Park, J. G., Frucht, H., Larocca, R. V., Bliss, D. P. Jr., Kurita, Y., Chen, T., Henslee, J. G., Trepel, J. B., Jensen, R. T., Johnson, B. E., Bang, Y-J, Kim, J. P. & Gazdar, A. F. (1990). Characteristics of cell lines established from human gastric carcinoma. Cancer Res 50: 2773–2780.
Park, J. G., Yang, H. K., Kim, W. H., Chung, J. K., Kang, M. S., Lee, J. H., Oh, J. H., Park, H. S., Yeo, K. S., Kang, S. H., Song, S. Y., Kang, Y. K., Bang, Y-J, Kim, Y. I. & Kim, J. P. (1997). Establishment and characterization of human gastric carcinoma cell lines. Int J Cancer 70: 443–449.
Park, K., Kim, S-J, Bang, Y-J, Park, J. G., Kim, N. K., Roberts, A. B. & Sporn, M. B. (1994). Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 91: 8772–8776.
Pietenpol, J. A., Stein, R. W., Moran, E., Yaciuk, P., Schlegel, R., Lyons, R. M., Pittelkow, M. R., Munger, K., Howley, M. R. & Moses, H. L. (1990). TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61: 777–785.
Polyak, K. (1996). Negative regulation of cell growth by TGF-β. Biochem Biophys Acta 1242: 185–199.
Polyak, K., Kato, J., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M. & Koff, A. (1994a). p27Kip1, a cyclin–CDK inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8: 9–22.
Polyak, K., Lee, M. H., Ergumnet-Bromage, H., Koff, A., Rorberts, J. M., Tempst, P. & Massague, J. (1994b). Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59–66.
Reynisdottir, I., Polyak, K., Iavarone, A. & Massague, J. (1995). Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev 9: 1831–1845.
Saha, P., Eichbaum, Q., Silberman, E. D., Mayer, B. J. & Dutta, A. (1997). p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases. Mol Cell Biol 17: 4338–4345.
Wrana, J. L., Attisano, L., Wieser, R., Ventura, F. & Massague, J. (1994). Mechanism of activation of the TGF-β receptor. Nature 370: 341–347.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Kang, S., Bang, YJ., Jong, HS. et al. Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-β-induced cell cycle arrest of gastric carcinoma cells. Br J Cancer 80, 1144–1149 (1999). https://doi.org/10.1038/sj.bjc.6690478
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690478
Keywords
This article is cited by
-
Targeting TGFβ signal transduction for cancer therapy
Signal Transduction and Targeted Therapy (2021)
-
CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-β signaling
Oncogene (2008)
-
SRF is a nuclear repressor of Smad3-mediated TGF-β signaling
Oncogene (2007)
-
Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer
Oncogene (2004)
-
AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity
Oncogene (2004)